- AI-Discovered Drug Reverses Aging Markers In Study, Biotech Says  Bloomberg.com
- Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  Nature
- Early Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York Times
- AI-designed drug candidate reverses biological age in clinical study  news-medical.net
- Insilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJ
​AI-Discovered Drug Reverses Aging Markers In Study, Biotech Says  Bloomberg.comIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  NatureEarly Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York TimesAI-designed drug candidate reverses biological age in clinical study  news-medical.netInsilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJ by Soban News (international And National News)